Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Andersen

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.
Muscle & Nerve|July 27, 2010
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Archives of Neurology|September 19, 2012
"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys TrialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Brain : a Journal of Neurology|March 17, 2025
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndromeRobin C M Thomma, Susan K Halstead, Laura C de Koning, et al.
Neurology|August 18, 2022
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 CohortSonja E Leonhard, Annemiek A van der Eijk, Henning Andersen, et al.
Neurology|April 19, 2023
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré SyndromeHelle Al-Hakem, Alex Y Doets, Amro Maher Stino, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.
Muscle & Nerve|July 27, 2010
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Archives of Neurology|September 19, 2012
"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys TrialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Brain : a Journal of Neurology|March 17, 2025
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndromeRobin C M Thomma, Susan K Halstead, Laura C de Koning, et al.
Neurology|August 18, 2022
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 CohortSonja E Leonhard, Annemiek A van der Eijk, Henning Andersen, et al.
Neurology|April 19, 2023
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré SyndromeHelle Al-Hakem, Alex Y Doets, Amro Maher Stino, et al.
Pageof 17